Business Description
Rhythm Biosciences Ltd
ISIN : AU000000RHY2
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 32.39 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -15.6 | |||||
3-Year EPS without NRI Growth Rate | -2.9 | |||||
3-Year FCF Growth Rate | -10.1 | |||||
3-Year Book Growth Rate | 17.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.72 | |||||
9-Day RSI | 31.81 | |||||
14-Day RSI | 35.75 | |||||
6-1 Month Momentum % | -44.12 | |||||
12-1 Month Momentum % | -80.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.05 | |||||
Quick Ratio | 2.04 | |||||
Cash Ratio | 1.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.9 | |||||
Shareholder Yield % | -3.06 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -162.71 | |||||
ROA % | -131.53 | |||||
ROIC % | -657.54 | |||||
ROC (Joel Greenblatt) % | -1290.79 | |||||
ROCE % | -145.44 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 15.5 | |||||
EV-to-EBIT | -2.5 | |||||
EV-to-EBITDA | -2.58 | |||||
EV-to-FCF | -2.6 | |||||
Price-to-Net-Current-Asset-Value | 4.85 | |||||
Price-to-Net-Cash | 4.85 | |||||
Earnings Yield (Greenblatt) % | -39.92 | |||||
FCF Yield % | -40.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Rhythm Biosciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.024 | ||
Beta | 0 | ||
Volatility % | 63.42 | ||
14-Day RSI | 35.75 | ||
14-Day ATR (€) | 0.00131 | ||
20-Day SMA (€) | 0.05267 | ||
12-1 Month Momentum % | -80.34 | ||
52-Week Range (€) | 0.0485 - 0.394799 | ||
Shares Outstanding (Mil) | 245.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Rhythm Biosciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Rhythm Biosciences Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Rhythm Biosciences Ltd Frequently Asked Questions
What is Rhythm Biosciences Ltd(FRA:0RY)'s stock price today?
When is next earnings date of Rhythm Biosciences Ltd(FRA:0RY)?
Does Rhythm Biosciences Ltd(FRA:0RY) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |